secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decibel Therapeutics, Inc. (—)
CIK:        0001656536
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0000950170-23-012063
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Decibel Therapeutics amends bylaws to update proxy rules and stockholder meeting procedures
--------------------------------------------------------------------------------

- Eliminated requirement to make stockholder list available during the actual meeting.
- Added provisions for adjourning meetings due to technical failure in remote communication.
- Enhanced disclosure requirements for stockholder nominations and proposals under universal proxy rules.
- Requires evidence of compliance with Rule 14a-19 solicitation requirements at least 5 business days before meeting.
- Non-compliant nominations will be disregarded; proxies for such nominees not counted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1656536/000095017023012063/0000950170-23-012063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1656536/000095017023012063/dbtx-20230404.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-012063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer